EFG Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,597
| Closed | -$2.36M | – | 195 |
|
|
2024
Q2 | $2.36M | Sell |
25,597
-1,007
| -4% | -$93K | 0.41% | 90 |
|
|
2024
Q1 | $2.54M | Buy |
26,604
+9,837
| +59% | +$940K | 0.44% | 82 |
|
|
2023
Q4 | $1.28M | Buy |
16,767
+9,241
| +123% | +$705K | 0.24% | 153 |
|
|
2023
Q3 | $521K | Sell |
7,526
-6,560
| -47% | -$455K | 0.12% | 186 |
|
|
2023
Q2 | $1.33M | Sell |
14,086
-7,888
| -36% | -$744K | 0.29% | 120 |
|
|
2023
Q1 | $1.82M | Buy |
21,974
+8,406
| +62% | +$695K | 0.4% | 84 |
|
|
2022
Q4 | $1.02M | Sell |
13,568
-51,553
| -79% | -$3.88M | 0.23% | 149 |
|
|
2022
Q3 | $5.39M | Sell |
65,121
-5,558
| -8% | -$460K | 1.24% | 20 |
|
|
2022
Q2 | $6.73M | Sell |
70,679
-6,732
| -9% | -$641K | 1.42% | 13 |
|
|
2022
Q1 | $9.12M | Sell |
77,411
-5,993
| -7% | -$706K | 1.37% | 17 |
|
|
2021
Q4 | $10.8M | Buy |
+83,404
| New | +$10.8M | 1.41% | 19 |
|